• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

November 15, 2023

Adult Insomnia Is Related to Sleep Problems in Childhood, Suggesting Insomnia Has a Genetic Component

Author(s):

Erin Hunter, Assistant Editor

The genes that predispose a person to sleep problems can impact that person across their entire lifetime, so interventions targeted toward a younger audience could be beneficial.

Adults with insomnia may have a genetic predisposition to it, according to the results of a new study published in the Journal of Psychology and Psychiatry. According to the findings, the genetic propensity for insomnia can be linked to poor sleep traits as a child.

Takeaways

  • Early-life stress alone can have a very negative impact on a developing brain.
  • Stress alone or combined with traumatic brain injury can make the brain more vulnerable, leading to potential negative programming that affects someone later in life.
  • Combined, stress and head injury may impact the oxytocin pathway, which is associated with social bonding.
  • Early-life stress alone impacted risk-taking behavior later in life.

Image credit: Prostock-studio | stock.adobe.com

Image credit: Prostock-studio | stock.adobe.com

“This is the first study providing direct evidence that genetic susceptibility for poor sleep is reflected in sleep problems already in early childhood,” study authors write in the paper. “By showing that genes predisposing adults to insomnia play a role in poor sleep from toddlerhood to adolescence, we provide indirect evidence for a persistency of the ‘poor sleeper’ phenotype across the lifetime.”

Investigators conducted the study to determine whether the genetics that predispose adults to insomnia or longer sleep duration are associated with sleep problems during childhood and adolescence. During the trial, investigators evaluated children's polygenic risk scores (PRS) for insomnia (PRS-I) and sleep duration (PRS-SD). The study enrolled 2458 children whose parentsreported a score on the insomnia-related items section of the Child Behavior Checklist at ages 1.5, 3, and 6 years. The parents also reported sleep scores at ages 10 to 15 years.

Children with a higher PRS-I score were reported to have more insomnia-related problems during early childhood and adolescence (BPRS-I < 0.001 = .09, 95% CI: 0.05; 0.14), but children with a higher PRS-SD appeared to have longer sleep duration (BPRS-SD < 5e08 = .05, 95% CI: 0.001; 0.09). Further, between the ages of 10 and 15 years, patients who slept longer were more likely to be awake during the night (BPRS-SD < 0.005 = .25, 95% CI: 0.04; 0.47).

Investigators also found that the genes predisposing someone to insomnia, while having much overlap with genes associated with longer sleep duration, are slightly different. A subgroup analysis of patients aged 10 to 15 years showed that patients with a genetic predisposition for longer reported sleep duration had longer sleep, but woke up more during the middle of the night.

There is a possibility that some of the findings are due to chance. The clinical or ecological implications, as well as methodology in which the study was conducted, are limited, according to the authors. Finally, the reported sleep scores cannot be generalized by ethnicity.

Up to 30% of children aged 1 to 12 years may suffer from sleep problems; these can manifest as trouble falling asleep, waking up frequently from sleep, or not getting enough sleep. Sleep problems that affect children and adolescents can carry over into adulthood, where the current remission rate is less than half (40%) and pharmaceuticals do not offer significant relief.

Other studies suggest that sleep interventions at an earlier age may positively impact behavioral outcomes that are linked to sleep. Some of these studies suggest that treating insomnia or sleep-related problems at an earlier age may stave of affective disorders, such as depression, in adulthood.

“Our results highlight the importance of considering qualitative, quantitative, objective, and subjective sleep characteristics from early age onwards,” the authors concluded. “The manifestation of genetic liability in sleep phenotypes early in life offers potential targets for early risk estimation, detection, prevention, and intervention, with possible long-term benefits.”

Reference

Kocevska D, Trajanoska K, Mulder RH, et al. Are some children genetically predisposed to poor sleep? A polygenic risk study in the general population. J Child Psychol Psychiatr. November 8, 2023. DOI: 10.1111/jcpp.13899

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
Image credit: komokvm | stock.adobe.com
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
Related Content
Advertisement
Doctor vaccinating baby in clinic. Little baby get an injection. Pediatrician vaccinating newborn baby. Vaccine for infant child.
May 29th 2025

Pneumococcal 15-Valent Conjugate Vaccine Provides Heightened Protection Against Certain Serotypes Compared With PCV13

Luke Halpern, Assistant Editor
MEDcast logo
August 16th 2024

Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust with Parents

Trisha Winroth, PharmD Ashly McPhillips, PharmD
Medical bottle with meningococcal disease vaccine and syringe, 3D rendering - Image credit: Alexey Novikov | stock.adobe.com
May 28th 2025

Quadrivalent Meningococcal Vaccine Receives FDA Approval for Infants and Children With Meningococcal Disease

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting
March 21st 2024

Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Young child having his height measured by his mother -- Image credit: DimaBerlin | stock.adobe.com
May 22nd 2025

Sogroya Observed as Efficacious and Well-Tolerated in Children With Growth Disorders

Gillian McGovern, Associate Editor
Related Content
Advertisement
Doctor vaccinating baby in clinic. Little baby get an injection. Pediatrician vaccinating newborn baby. Vaccine for infant child.
May 29th 2025

Pneumococcal 15-Valent Conjugate Vaccine Provides Heightened Protection Against Certain Serotypes Compared With PCV13

Luke Halpern, Assistant Editor
MEDcast logo
August 16th 2024

Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust with Parents

Trisha Winroth, PharmD Ashly McPhillips, PharmD
Medical bottle with meningococcal disease vaccine and syringe, 3D rendering - Image credit: Alexey Novikov | stock.adobe.com
May 28th 2025

Quadrivalent Meningococcal Vaccine Receives FDA Approval for Infants and Children With Meningococcal Disease

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting
March 21st 2024

Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Young child having his height measured by his mother -- Image credit: DimaBerlin | stock.adobe.com
May 22nd 2025

Sogroya Observed as Efficacious and Well-Tolerated in Children With Growth Disorders

Gillian McGovern, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.